APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chromosomal Microarray Analysis (CMA) Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Chromosomal Microarray Analysis (CMA) Testing Market Analysis and Forecast 2026-2032

17 January 2026197 pages

Choose your research edition.

Industry ResearchChromosomal Microarray Analysis (CMA) Testing Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Chromosomal Microarray Analysis (CMA) Testing Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Chromosomal Microarray Analysis (CMA) Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chromosomal Microarray Analysis (CMA) Testing Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Chromosomal Microarray Analysis (CMA) Testing Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Chromosomal Microarray Analysis (CMA) Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Chromosomal Microarray Analysis (CMA) Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Chromosomal Microarray Analysis (CMA) Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Chromosomal Microarray Analysis (CMA) Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Chromosomal Microarray Analysis (CMA) Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Chromosomal Microarray Analysis (CMA) Testing include Baylor Genetics, MedGenome Labs, Illumina Inc., CD Genomics, Thermo Fisher, Agilent, GeneDx, Quest Diagnostics and LabCorp, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Chromosomal Microarray Analysis (CMA) Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Chromosomal Microarray Analysis (CMA) Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Chromosomal Microarray Analysis (CMA) Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chromosomal Microarray Analysis (CMA) Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Chromosomal Microarray Analysis (CMA) Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Chromosomal Microarray Analysis (CMA) Testing revenue, projected growth trends, production technology, application and end-user industry.

Chromosomal Microarray Analysis (CMA) Testing Segment by Company

Baylor Genetics

MedGenome Labs

Illumina Inc.

CD Genomics

Thermo Fisher

Agilent

GeneDx

Quest Diagnostics

LabCorp

Lineagen

Invitae

Centogene

Chromosomal Microarray Analysis (CMA) Testing Segment by Type

Single Nucleotide Polymorphism (SNP)

Comparative Genomic Hybridization (CGH)

Chromosomal Microarray Analysis (CMA) Testing Segment by Application

Medical

Laboratory

Clinical

Others

Chromosomal Microarray Analysis (CMA) Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chromosomal Microarray Analysis (CMA) Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chromosomal Microarray Analysis (CMA) Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chromosomal Microarray Analysis (CMA) Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Chromosomal Microarray Analysis (CMA) Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Chromosomal Microarray Analysis (CMA) Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chromosomal Microarray Analysis (CMA) Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single Nucleotide Polymorphism (SNP) Major Player Table 3. Comparative Genomic Hybridization (CGH) Major Player Table 4. Global Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Medical Major Player Table 6. Laboratory Major Player Table 7. Clinical Major Player Table 8. Others Major Player Table 9. Chromosomal Microarray Analysis (CMA) Testing Industry Trends Table 10. Chromosomal Microarray Analysis (CMA) Testing Industry Drivers Table 11. Chromosomal Microarray Analysis (CMA) Testing Industry Opportunities and Challenges Table 12. Chromosomal Microarray Analysis (CMA) Testing Industry Restraints Table 13. Global Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Chromosomal Microarray Analysis (CMA) Testing Market Share by Region (2021-2026) Table 16. Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Chromosomal Microarray Analysis (CMA) Testing Market Share by Region (2027-2032) Table 18. Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share by Players (2021-2026) Table 20. Global Chromosomal Microarray Analysis (CMA) Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Chromosomal Microarray Analysis (CMA) Testing Key Players Headquarters & Area Served Table 22. Global Chromosomal Microarray Analysis (CMA) Testing Players, Product Type & Application Table 23. Global Chromosomal Microarray Analysis (CMA) Testing Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Chromosomal Microarray Analysis (CMA) Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share by Type (2021-2026) Table 30. Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share by Type (2027-2032) Table 31. Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share by Application (2021-2026) Table 35. Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share by Application (2027-2032) Table 36. Baylor Genetics Company Information Table 37. Baylor Genetics Business Overview Table 38. Baylor Genetics Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Baylor Genetics Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 40. Baylor Genetics Recent Development Table 41. MedGenome Labs Company Information Table 42. MedGenome Labs Business Overview Table 43. MedGenome Labs Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. MedGenome Labs Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 45. MedGenome Labs Recent Development Table 46. Illumina Inc. Company Information Table 47. Illumina Inc. Business Overview Table 48. Illumina Inc. Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Illumina Inc. Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 50. Illumina Inc. Recent Development Table 51. CD Genomics Company Information Table 52. CD Genomics Business Overview Table 53. CD Genomics Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. CD Genomics Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 55. CD Genomics Recent Development Table 56. Thermo Fisher Company Information Table 57. Thermo Fisher Business Overview Table 58. Thermo Fisher Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Thermo Fisher Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 60. Thermo Fisher Recent Development Table 61. Agilent Company Information Table 62. Agilent Business Overview Table 63. Agilent Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Agilent Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 65. Agilent Recent Development Table 66. GeneDx Company Information Table 67. GeneDx Business Overview Table 68. GeneDx Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. GeneDx Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 70. GeneDx Recent Development Table 71. Quest Diagnostics Company Information Table 72. Quest Diagnostics Business Overview Table 73. Quest Diagnostics Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Quest Diagnostics Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 75. Quest Diagnostics Recent Development Table 76. LabCorp Company Information Table 77. LabCorp Business Overview Table 78. LabCorp Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. LabCorp Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 80. LabCorp Recent Development Table 81. Lineagen Company Information Table 82. Lineagen Business Overview Table 83. Lineagen Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Lineagen Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 85. Lineagen Recent Development Table 86. Invitae Company Information Table 87. Invitae Business Overview Table 88. Invitae Chromosomal Microarray Analysis (CMA) Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Invitae Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 90. Invitae Recent Development Table 91. Centogene Company Information Table 92. Centogene Business Overview Table 93. Centogene Chromosomal Microarray Analysis (CMA) Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Centogene Chromosomal Microarray Analysis (CMA) Testing Product Portfolio Table 95. Centogene Recent Development Table 96. North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (US$ Million) & (2027-2032) Table 110. China Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2026) & (US$ Million) Table 111. China Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2027-2032) & (US$ Million) Table 112. China Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2026) & (US$ Million) Table 113. China Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Chromosomal Microarray Analysis (CMA) Testing Image Figure 2. Global Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chromosomal Microarray Analysis (CMA) Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single Nucleotide Polymorphism (SNP) Image Figure 5. Comparative Genomic Hybridization (CGH) Image Figure 6. Global Chromosomal Microarray Analysis (CMA) Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Chromosomal Microarray Analysis (CMA) Testing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Medical Image Figure 9. Laboratory Image Figure 10. Clinical Image Figure 11. Others Image Figure 12. Global Chromosomal Microarray Analysis (CMA) Testing Market Size (US$ Million) & (2021-2032) Figure 13. Global Chromosomal Microarray Analysis (CMA) Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Chromosomal Microarray Analysis (CMA) Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Chromosomal Microarray Analysis (CMA) Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share by Type (2021-2032) Figure 20. Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share by Application (2021-2032) Figure 23. North America Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Type (2021-2032) Figure 25. North America Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Application (2021-2032) Figure 26. North America Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Country (2021-2032) Figure 27. United States Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Type (2021-2032) Figure 32. Europe Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Application (2021-2032) Figure 33. Europe Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Country (2021-2032) Figure 34. Germany Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Type (2021-2032) Figure 44. China Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Application (2021-2032) Figure 45. Asia Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Type (2021-2032) Figure 47. Asia Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Application (2021-2032) Figure 48. Asia Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Region (2021-2032) Figure 49. Japan Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Type (2021-2032) Figure 57. SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Application (2021-2032) Figure 58. SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Country (2021-2032) Figure 59. Brazil Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Chromosomal Microarray Analysis (CMA) Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Single Nucleotide Polymorphism (SNP)
  • Comparative Genomic Hybridization (CGH)
Applications
  • Medical
  • Laboratory
  • Clinical
  • Others
Companies covered
  • Baylor Genetics
  • MedGenome Labs
  • Illumina Inc.
  • CD Genomics
  • Thermo Fisher
  • Agilent
  • GeneDx
  • Quest Diagnostics
  • LabCorp
  • Lineagen
  • Invitae
  • Centogene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Chromosomal Microarray Analysis (CMA) Testing Market by Type
  3. 1.2.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Single Nucleotide Polymorphism (SNP)
  5. 1.2.3 Comparative Genomic Hybridization (CGH)
  6. 1.3 Chromosomal Microarray Analysis (CMA) Testing Market by Application
  7. 1.3.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Medical
  9. 1.3.3 Laboratory
  10. 1.3.4 Clinical
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Chromosomal Microarray Analysis (CMA) Testing Market Dynamics
  1. 2.1 Chromosomal Microarray Analysis (CMA) Testing Industry Trends
  2. 2.2 Chromosomal Microarray Analysis (CMA) Testing Industry Drivers
  3. 2.3 Chromosomal Microarray Analysis (CMA) Testing Industry Opportunities and Challenges
  4. 2.4 Chromosomal Microarray Analysis (CMA) Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Perspective (2021-2032)
  2. 3.2 Global Chromosomal Microarray Analysis (CMA) Testing Growth Trends by Region
  3. 3.2.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Players
  2. 4.1.1 Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Chromosomal Microarray Analysis (CMA) Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Chromosomal Microarray Analysis (CMA) Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Chromosomal Microarray Analysis (CMA) Testing Key Players Headquarters & Area Served
  7. 4.4 Global Chromosomal Microarray Analysis (CMA) Testing Players, Product Type & Application
  8. 4.5 Global Chromosomal Microarray Analysis (CMA) Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Chromosomal Microarray Analysis (CMA) Testing Market CR5 and HHI
  11. 4.6.3 2025 Chromosomal Microarray Analysis (CMA) Testing Tier 1, Tier 2, and Tier 3
5 Chromosomal Microarray Analysis (CMA) Testing Market Size by Type
  1. 5.1 Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2032)
  3. 5.3 Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share by Type (2021-2032)
6 Chromosomal Microarray Analysis (CMA) Testing Market Size by Application
  1. 6.1 Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2032)
  3. 6.3 Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Baylor Genetics
  2. 7.1.1 Baylor Genetics Company Information
  3. 7.1.2 Baylor Genetics Business Overview
  4. 7.1.3 Baylor Genetics Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Baylor Genetics Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  6. 7.1.5 Baylor Genetics Recent Developments
  7. 7.2 MedGenome Labs
  8. 7.2.1 MedGenome Labs Company Information
  9. 7.2.2 MedGenome Labs Business Overview
  10. 7.2.3 MedGenome Labs Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 MedGenome Labs Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  12. 7.2.5 MedGenome Labs Recent Developments
  13. 7.3 Illumina Inc.
  14. 7.3.1 Illumina Inc. Company Information
  15. 7.3.2 Illumina Inc. Business Overview
  16. 7.3.3 Illumina Inc. Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Illumina Inc. Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  18. 7.3.5 Illumina Inc. Recent Developments
  19. 7.4 CD Genomics
  20. 7.4.1 CD Genomics Company Information
  21. 7.4.2 CD Genomics Business Overview
  22. 7.4.3 CD Genomics Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 CD Genomics Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  24. 7.4.5 CD Genomics Recent Developments
  25. 7.5 Thermo Fisher
  26. 7.5.1 Thermo Fisher Company Information
  27. 7.5.2 Thermo Fisher Business Overview
  28. 7.5.3 Thermo Fisher Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Thermo Fisher Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  30. 7.5.5 Thermo Fisher Recent Developments
  31. 7.6 Agilent
  32. 7.6.1 Agilent Company Information
  33. 7.6.2 Agilent Business Overview
  34. 7.6.3 Agilent Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Agilent Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  36. 7.6.5 Agilent Recent Developments
  37. 7.7 GeneDx
  38. 7.7.1 GeneDx Company Information
  39. 7.7.2 GeneDx Business Overview
  40. 7.7.3 GeneDx Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GeneDx Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  42. 7.7.5 GeneDx Recent Developments
  43. 7.8 Quest Diagnostics
  44. 7.8.1 Quest Diagnostics Company Information
  45. 7.8.2 Quest Diagnostics Business Overview
  46. 7.8.3 Quest Diagnostics Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Quest Diagnostics Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  48. 7.8.5 Quest Diagnostics Recent Developments
  49. 7.9 LabCorp
  50. 7.9.1 LabCorp Company Information
  51. 7.9.2 LabCorp Business Overview
  52. 7.9.3 LabCorp Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 LabCorp Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  54. 7.9.5 LabCorp Recent Developments
  55. 7.10 Lineagen
  56. 7.10.1 Lineagen Company Information
  57. 7.10.2 Lineagen Business Overview
  58. 7.10.3 Lineagen Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Lineagen Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  60. 7.10.5 Lineagen Recent Developments
  61. 7.11 Invitae
  62. 7.11.1 Invitae Company Information
  63. 7.11.2 Invitae Business Overview
  64. 7.11.3 Invitae Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Invitae Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  66. 7.11.5 Invitae Recent Developments
  67. 7.12 Centogene
  68. 7.12.1 Centogene Company Information
  69. 7.12.2 Centogene Business Overview
  70. 7.12.3 Centogene Chromosomal Microarray Analysis (CMA) Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Centogene Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
  72. 7.12.5 Centogene Recent Developments
8 North America
  1. 8.1 North America Chromosomal Microarray Analysis (CMA) Testing Revenue (2021-2032)
  2. 8.2 North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2027-2032)
  5. 8.3 North America Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2027-2032)
  9. 8.5 North America Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Country
  11. 8.6.1 North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Chromosomal Microarray Analysis (CMA) Testing Revenue (2021-2032)
  2. 9.2 Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Country
  11. 9.6.1 Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Chromosomal Microarray Analysis (CMA) Testing Revenue (2021-2032)
  2. 10.2 China Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2027-2032)
  5. 10.3 China Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2027-2032)
  9. 10.5 China Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Chromosomal Microarray Analysis (CMA) Testing Revenue (2021-2032)
  2. 11.2 Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Country
  11. 11.6.1 Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue (2021-2032)
  2. 12.2 SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Country
  11. 12.6.1 SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Chromosomal Microarray Analysis (CMA) Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst